Repair & Recovery Stack
Three recovery peptides in one protocol, with each component's evidence described separately.
- Explored for soft-tissue recovery support
- KPV explored for an inflammatory component the other two are not studied for
- Used alongside a recovery plan rather than in place of one
Explored, not established. Each component is judged on its own limited evidence; combining them does not combine their evidence.
Pricing confirmed after eligibility · prescription treatment
What is in the Repair & Recovery Stack
The Repair & Recovery Stack combines BPC-157, KPV and TB-500. KPV is a short fragment of alpha-melanocyte-stimulating hormone studied for an anti-inflammatory effect, mostly in preclinical models of gut inflammation; the other two are studied for tissue repair. All three are prepared by a licensed compounding pharmacy under a prescription written for you, and none is FDA-approved.
How it works here
Every plan follows one path. Each step feeds the next. See the Peptide Therapy approach.
- 01
Measure
We baseline your labs, history, and goals.
- 02
Plan
A clinician decides whether this fits — and what else might serve you.
- 03
Act
If appropriate, you start with clear guidance and high-touch support.
- 04
Track
We monitor how you respond on a defined cadence.
- 05
Adjust
Protocols are refined over time. Guided care, not a kit in the mail.
Delivery
A compounded preparation, dispensed by a licensed pharmacy on an individual prescription. How it is taken is set by the prescribing clinician after a review.
Is it right for you?
Adults over 45 whose recovery problem has an inflammatory element as well as a structural one, who have had it properly worked up, and who want each component explained separately. See peptide therapy.
Often considered alongside
BPC-157
CompoundedA recovery peptide with far more discussion than proof — offered with the evidence stated plainly.
View treatmentWolverine Stack
CompoundedTwo recovery peptides used together, with the gap in the evidence stated rather than glossed.
View treatmentGI Effects + Microbiomix
Lab-developed testAn expanded gut panel pairing comprehensive stool analysis with deeper microbiome sequencing.
View treatmentProducts marked Compounded are prepared by a licensed compounding pharmacy under a prescription written for you. Compounded medications are not FDA-approved and are not equivalent to or interchangeable with any branded product.
An honest word on the evidence
A three-peptide protocol is not three times the evidence, and it is worth saying so before anything else. Each component carries its own thin, largely preclinical literature, and no published trial has tested the three together. What the combination offers is a wider mechanistic rationale, and that is a reason to consider it, not a reason to expect a result. These peptides sit in an unsettled regulatory position. In April 2026 the FDA removed twelve peptide substances from Category 2 of its interim 503A bulk substances list, this one among them — a step that followed the nominators withdrawing their nominations rather than any safety finding, and one that does not by itself authorize compounding. In July 2026 the Pharmacy Compounding Advisory Committee voted on whether seven of them should be added to the 503A Bulks List. That vote is a recommendation, not a decision: formal addition requires notice-and-comment rulemaking, which has not completed. Nothing here is FDA-approved for any use.
Frequently asked questions
An inflammatory angle the other two are not primarily studied for. What KPV adds covers where that evidence comes from and how far it goes.
The Wolverine Stack is BPC-157 and TB-500. This adds KPV.
No. All three are compounded preparations and none is approved for any use.
Not in a published trial. The rationale is mechanistic and should be understood as such.
See if Repair & Recovery Stack fits your plan
The right plan begins with knowing where you are. Start with a short eligibility check and a baseline — and we'll tell you, honestly, what fits.
We measure first. Then we act.
ACT 2 Health provides clinician-led care. Treatments described are available only to eligible patients following clinical evaluation and within applicable regulations. This page is educational and is not medical advice. Individual results vary.